| Literature DB >> 35627704 |
Maja Czerwińska-Rogowska1, Karolina Skonieczna-Żydecka2, Krzysztof Kaseja3, Karolina Jakubczyk1, Joanna Palma2, Marta Bott-Olejnik4, Sławomir Brzozowski4, Ewa Stachowska1.
Abstract
BACKGROUND AND AIMS: Strokes are the second highest cause of death in the world and the most common cause of permanent disability in adults. Intestinal barrier permeability thus contributes to diminished homeostasis within the body, which further affects the healing process and convalescence. Each stroke patient should be administered with ingredients that support the intestinal barrier (e.g., protein and fiber). The aim of this study was to compare the effect of various types of diet (enteral with or without fiber vs. a mixed kitchen diet) on the metabolic activity of intestinal microbiota, namely short chain fatty acids, and gut barrier integrity parameters (zonulin and calprotectin.Entities:
Keywords: enteral nutrition; ischemic stroke; malnutrition; mixed kitchen diet
Mesh:
Substances:
Year: 2022 PMID: 35627704 PMCID: PMC9141131 DOI: 10.3390/ijerph19106168
Source DB: PubMed Journal: Int J Environ Res Public Health ISSN: 1660-4601 Impact factor: 4.614
Figure 1Study diagram. BMI—Body Mass Index, MAMC—mid-arm muscle circumference, CHC—cholesterol level, TG—triglycerides level.
Comparison of blood biochemical parameters and anthropometric measurements in patients on Day 1 of the study.
| Blenderized | Nutrison | Nutrison Diason |
| |
|---|---|---|---|---|
| BMI (kg/m2) | 24.9 ± 24.9 | 24.6 ± 3.8 | 23.8 ± 3.8 | ns |
| Body mass | 64.7 ± 10.5 | 62.9 ± 12.0 | 63.1 ± 10.4 | ns |
| MAMC | 31.8 ± 4.5 | 29.7 ± 2.7 | 29.3 ± 2.9 | ns |
| Calf circumference (cm) | 34.4 ± 4.2 | 32.8 ± 3.7 | 33.4 ± 3.0 | ns |
| Total cholesterol (mg/dL) | 181 ± 49 | 160 ± 49 | 182 ± 53 | ns |
| Triglycerides (mg/dL) | 119 ± 63 | 130 ± 83 | 109 ± 37 | ns |
| Glucose (mg/dL) | 158 ± 49 | 131 ± 38 | 166 ± 43 | ns |
| Creatinine (mg/dL) | 0.9 ± 0.4 | 1.0 ± 0.3 | 1.0 ± 0.6 | ns |
| Lymphocytes (tys/µL) | 1.73 ± 0.78 | 1.5 ± 0.83 | 2.31 ± 1.5 | ns |
| Erythrocytes (mln/µL) | 4.67 ± 0.51 | 3.88 ± 0.88 | 4.96 ± 0.61 | ns |
| Haemoglobin (g/dL) | 13.95 ± 1.52 | 11.19 ± 2.51 | 14.18 ± 0.61 | ns |
| CRP (mg/L) | 31.23 ± 44.47 | 80.51 ± 68.05 | 58.27 ± 87.27 | ns |
MAMC—Mid-arm muscle circumference.
Nutritional content according to nutrition software vs. laboratory determinations in the diets.
| Dry Matter (%) | Protein (g) | Fat (g) | Total Fibre (g) | Ash | |
|---|---|---|---|---|---|
| Kitchen diet, content determined in 100 mL | 10.4% | 2.4 | 4.5 | 1.1 | 0.68 |
| Kitchen diet, content according to the software per 100 mL | No | 4.2 | 4.4 | 2.4 | 0.9 |
| Nutrison Energy diet, content determined in 100mL | 29% | 5.4 | 5.2 | 0.02 | 0.92 |
| Nutrison Energy, content declared by the manufacturer per 100 mL | No | 6.2 | 5.8 | <0.1 | No |
| Nutrison Diason Energy HP diet, content determined in 100 mL | 28.10% | 7.1 | 7.7 | 1.8 | 0.8 |
| Nutrison Diason Energy HP diet, declared by the manufacturer per 100 mL | No | 7.7 | 7.7 | 1.5 | No |
Anthropometric and gut barrier parameters (short and branched fatty acids, zonulin, calprotectin) in studied groups by diet type and time of analysis (mean ± SD).
| Kitchen Diet before | Kitchen Diet after | Nutrison Diason Energy HP before | Nutrison Diason Energy HP after | Nutrison Energy before | Nutrison Energy after | |
|---|---|---|---|---|---|---|
| MEAN ± SD | MEAN ± SD | MEAN ± SD | MEAN ± SD | MEAN ± SD | MEAN ± SD | |
| Lymphocytes [103/µL] | 1.73 ± 0.78 * | 1.33 ± 0.66 * | 2.31 ± 1.5 | 2.38 ± 1.8 | 1.5 ± 0.8 | 1.52 ± 0.48 |
| Erythrocytes [106/µL] | 4.67 ± 0.51 * | 4.27 ± 0.65 * | 4.96 ± 0.61 * | 4.3 ± 0.5 * | 3.88 ± 0.9 | 4.96 ± 0.6 |
| Haemoglobin [g/dL] | 13.95 ± 1.5 * | 12.8 ± 2.1 * | 14.18 ± 1.5 * | 12.3 ± 1.8 * | 11.2 ± 10.6 | 11.22 ± 2.7 |
| CRP [mg/L] | 31.2 − 2.7 * | 68.8 − 25.1 * | 58.3 ± 11.7 | 46.2 ± 30.5 | 80.51 ± 78.3 | 77.04 ± 55.4 |
| Body weight (kg) | 64.7 ± 10.5 * | 63.7 ± 9.9 * | 63.1 ± 10.4 | 62.9 ± 10.5 | 62.9 ± 12.0 | 62.5 ± 12.1 |
| BMI (kg/m2) | 24.9 ± 4.2 * | 24.5 ± 4.1 * | 23.8 ± 3.8 | 23.1 ± 3.8 | 24.6 ± 3.8 | 23.7 ± 3.3 |
| Calprotectin (ug/mL) | 814 ± 629 | 1225 ± 162 | 1163 ± 830 | 1398 ± 805 | 1042 ± 1053 | 1376 ± 688 |
| Zonulin (ng/mL) | 410.3 ± 168 * | 431.1 ± 137 * | 421 ± 138 | 477 ± 161 | 397 ± 165 | 482 ± 138 |
| Acetic acid (%) | 27.9 ± 12.4 | 29.2 ± 7.6 | 35.9 ± 5.2 | 36.4 ± 4.7 | 31.5 ± 8.5 | 37.0 ± 11.9 |
| Butyric acid (%) | 20.2 * ± 7.2 | 16.1 * ± 5.9 | 16.8 ± 3.8 | 16.0 ± 2.7 | 14.6 ± 5.3 | 12.3 ± 6.6 |
| Propionic acid (%) | 16.3 * ± 5.8 | 18.9 * ± 6.2 | 17.9 ± 3.8 | 19.9 ± 7.6 | 18.4 ± 5.0 | 18.3 ± 7.1 |
| Isobutyric acid (%) | 7.9 ± 5.1 | 8.6 ± 7.6 | 5.7 ± 1.0 | 5.7 ± 1.2 | 6.6 ± 1.5 | 6.7 ± 2.0 |
| Isovaleric acid (%) | 15.0 ± 3.7 | 14.4 ± 3.3 | 12.4 * ± 2.3 | 12.8 * ± 29 | 13.8 ± 3.6 | 15.3 ± 4.4 |
| Valeric acid (%) | 7.7 ± 2.2 | 7.4 ± 2.1 | 7.2 * ± 0.8 | 6.7 * ± 1.4 | 7.3 ± 2.5 | 6.0 ± 2.2 |
| Isocaproic acid (%) | 1.2 * ± 27 | 1.7 * ± 1.5 | 1.5 ± 0.5 | 1.0 ± 0.4 | 2.6 ± 2.4 | 1.7 ± 2.2 |
| Caproic acid (%) | 2.5 ± 2.7 | 2.1 ± 1.7 | 1.6 * ± 0.7 | 0.8 * ± 0.3 | 2.7 ± 2.4 | 1.4 ± 2.0 |
| Heptanoic acid (%) | 1.3 ± 2.9 | 1.6 ± 1.8 | 1.1 * ± 0.6 | 0.7 * ± 0.4 | 2.53 ± 2.6 | 1.3 ± 2.2 |
BMI—Body Mass Index; SD—Standard Deviation. * p < 0.05.
Figure 2Effects of enteral diets on fecal zonulin release.
Analysis of covariance ANCOVA for fecal calprotectin concentrations.
| SS | Degrees of Freedom | MS | F |
| |
|---|---|---|---|---|---|
| Caloric intake | 451,086 | 1 | 451,086 | 0.93634 | 0.338071 |
| Type of diet | 1,228,154 | 2 | 614,077 | 1.27467 | 0.288814 |
| Antibiotics | 127,430 | 1 | 127,430 | 0.26451 | 0.609397 |
| Probiotics | 49,523 | 1 | 49,523 | 0.1028 | 0.749889 |
| PPI | 2,819,281 | 1 | 2,819,281 | 5.85211 | 0.019398 |
PPI—proton pump inhibitors.
Figure 3Effects of proton pump inhibitors on fecal calprotectin concentrations.
Figure 4Overview of the results.